Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 17:2:756689.
doi: 10.3389/fopht.2022.756689. eCollection 2022.

Grand Challenges in Ocular Inflammatory Diseases

Heping Xu  1   2 , Narsing A Rao  3   4
Affiliations
Editorial

Grand Challenges in Ocular Inflammatory Diseases

Heping Xu et al. Front Ophthalmol (Lausanne). .
No abstract available

Keywords: aging; artificial intelligence; blood ocular barrier; degeneration; inflammation; machine learning; microbiome; omics technology.

PubMed Disclaimer

Conflict of interest statement

HX has a sponsored research agreement with Boehringre Ingelheim and a consultant agreement with F. Hoffmann-La Roche Ltd. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, Prevalence, and Risk Factors of Infectious Uveitis and Scleritis in the United States: A Claims-Based Analysis. PloS One (2020) 15:e0237995. doi: 10.1371/journal.pone.0237995 - DOI - PMC - PubMed
    1. Delogu LG, Deidda S, Delitala G, Manetti R. Infectious Diseases and Autoimmunity. J Infect Dev Ctries (2011) 5:679–87. doi: 10.3855/jidc.2061 - DOI - PubMed
    1. Gu W, Miller S, Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. Annu Rev Pathol: Mech Dis (2019) 14:319–38. doi: 10.1146/annurev-pathmechdis-012418-012751 - DOI - PMC - PubMed
    1. Park J, Langmead CJ, Riddy DM. New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery. ACS Pharmacol Transl Sci (2020) 3:88–106. doi: 10.1021/acsptsci.9b00075 - DOI - PMC - PubMed
    1. Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, et al. . Development of an Activity Disease Score in Patients With Uveitis (UVEDAI). Rheumatol Int (2017) 37:647–56. doi: 10.1007/s00296-016-3593-1 - DOI - PMC - PubMed

Publication types

LinkOut - more resources